The Central Vein Sign in Radiologically Isolated Syndrome

REFERENCES

1. 1.↵
   2. Thompson AJ,
   3. Baranzini SE,
   4. Geurts J, et al

   . Multiple sclerosis. Lancet 2018;391:1622–36 doi:10.1016/S0140-6736(18)30481-1 pmid:29576504

   CrossRefPubMed
2. 2.↵
   2. Adams CW,
   3. Abdulla YH,
   4. Torres EM, et al

   . Periventricular lesions in multiple sclerosis: their perivenous origin and relationship to granular ependymitis. Neuropathol Appl Neurobiol 1987;13:141–52 doi:10.1111/j.1365-2990.1987.tb00177.x pmid:3614542

   CrossRefPubMed
3. 3.↵
   2. Solomon AJ,
   3. Schindler MK,
   4. Howard DB, et al

   . “Central vessel sign” on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine. Ann Clin Transl Neurol 2016;3:82–87 doi:10.1002/acn3.273 pmid:26900578

   CrossRefPubMed
4. 4.↵
   2. Polman CH,
   3. Reingold SC,
   4. Edan G, et al

   . Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria.” Ann Neurol 2005;58:840–46 doi:10.1002/ana.20703 pmid:16283615

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Polman CH,
   3. Reingold SC,
   4. Banwell B, et al

   . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292–302 doi:10.1002/ana.22366 pmid:21387374

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Thompson AJ,
   3. Banwell BL,
   4. Barkhof F, et al

   . Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018;17:162–73 doi:10.1016/S1474-4422(17)30470-2 pmid:29275977

   CrossRefPubMed
7. 7.↵
   2. Tallantyre EC,
   3. Brookes MJ,
   4. Dixon JE, et al

   . Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology 2008;70:2076–78 doi:10.1212/01.wnl.0000313377.49555.2e pmid:18505982

   FREE Full Text
8. 8.↵
   2. Tallantyre EC,
   3. Dixon JE,
   4. Donaldson I, et al

   . Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions. Neurology 2011;76:534–39 doi:10.1212/WNL.0b013e31820b7630 pmid:21300968

   Abstract/FREE Full Text
9. 9.↵
   2. Sati P,
   3. Thomasson DM,
   4. Li N, et al

   . Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis. Mult Scler 2014;20:1464–70 doi:10.1177/1352458514525868 pmid:24639479

   CrossRefPubMed
10. 10.↵
    2. Mistry N,
    3. Abdel-Fahim R,
    4. Samaraweera A, et al

    . Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions. Mult Scler 2016;22:1289–96 doi:10.1177/1352458515616700 pmid:26658816

    CrossRefPubMed
11. 11.↵
    2. Sati P,
    3. Oh J,
    4. Constable RT, et al

    . The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol 2016;12:714–22 doi:10.1038/nrneurol.2016.166 pmid:27834394

    CrossRefPubMed
12. 12.↵
    2. Sati P,
    3. George IC,
    4. Shea CD, et al

    . FLAIR*: a combined MR contrast technique for visualizing white matter lesions and parenchymal veins. Radiology 2012;265:926–32 doi:10.1148/radiol.12120208 pmid:23074257

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Kau T,
    3. Taschwer M,
    4. Deutschmann H, et al

    . The “central vein sign”: is there a place for susceptibility weighted imaging in possible multiple sclerosis? Eur Radiol 2013;23:1956–62 doi:10.1007/s00330-013-2791-4 pmid:23436147

    CrossRefPubMed
14. 14.↵
    2. Samaraweera AP,
    3. Clarke MA,
    4. Whitehead A, et al

    . The central vein sign in multiple sclerosis lesions is present irrespective of the T2* sequence at 3 T. J Neuroimaging 2017;27:114–21 doi:10.1111/jon.12367 pmid:27300318

    CrossRefPubMed
15. 15.↵
    2. Solomon AJ,
    3. Watts R,
    4. Ontaneda D, et al

    . Diagnostic performance of central vein sign for multiple sclerosis with a simplified three-lesion algorithm. Mult Scler 2018;24:750–57 doi:10.1177/1352458517726383 pmid:28820013

    CrossRefPubMed
16. 16.↵
    2. Sparacia G,
    3. Agnello F,
    4. Gambino A, et al

    . Multiple sclerosis: high prevalence of the ‘central vein’ sign in white matter lesions on susceptibility-weighted images. Neuroradiol J 2018;31:356–61 doi:10.1177/1971400918763577 pmid:29565219

    CrossRefPubMed
17. 17.↵
    2. Miller AE,
    3. Calabresi PA

    . Central vein sign in multiple sclerosis: ready for front and center? Neurology 2018;90:631–32 doi:10.1212/WNL.0000000000005241 pmid:29514945

    Abstract/FREE Full Text
18. 18.↵
    2. Inglese M,
    3. Fleysher L,
    4. Oesingmann N, et al

    . Clinical applications of ultra-high field magnetic resonance imaging in multiple sclerosis. Expert Rev Neurother 2018;18:221–30 doi:10.1080/14737175.2018.1433033 pmid:29369733

    CrossRefPubMed
19. 19.↵
    2. Hosseini Z,
    3. Matusinec J,
    4. Rudko DA, et al

    . Morphology-specific discrimination between MS white matter lesions and benign white matter hyperintensities using ultra-high-field MRI. AJNR Am J Neuroradiol 2018;39:1473–79 doi:10.3174/ajnr.A5705 pmid:29930096

    Abstract/FREE Full Text
20. 20.↵
    2. Lamot U,
    3. Avsenik J,
    4. Sega S, et al

    . Presence of central veins and susceptibility weighted imaging for evaluating lesions in multiple sclerosis and leukoaraiosis. Mult Scler Relat Disord 2017;13:67–72 doi:10.1016/j.msard.2017.02.008 pmid:28427705

    CrossRefPubMed
21. 21.↵
    2. Campion T,
    3. Smith RJP,
    4. Altmann DR, et al

    . FLAIR* to visualize veins in white matter lesions: a new tool for the diagnosis of multiple sclerosis? Eur Radiol 2017;27:4257–63 doi:10.1007/s00330-017-4822-z pmid:28409356

    CrossRefPubMed
22. 22.↵
    2. Maggi P,
    3. Absinta M,
    4. Grammatico M, et al

    . Central vein sign differentiates multiple sclerosis from central nervous system inflammatory vasculopathies. Ann Neurol 2018;83:283–94 doi:10.1002/ana.25146 pmid:29328521

    CrossRefPubMed
23. 23.↵
    2. Cortese R,
    3. Magnollay L,
    4. Tur C, et al

    . Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD. Neurology 2018;90:e1183–90 doi:10.1212/WNL.0000000000005256 pmid:29514948

    Abstract/FREE Full Text
24. 24.↵
    2. Okuda DT,
    3. Mowry EM,
    4. Beheshtian A, et al

    . Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology 2009;72:800–05 doi:10.1212/01.wnl.0000335764.14513.1a pmid:19073949

    Abstract/FREE Full Text
25. 25.↵
    2. Okuda DT,
    3. Siva A,
    4. Kantarci O, et al

    ; Radiologically Isolated Syndrome Consortium (RISC), Club Francophone de la Sclérose en Plaques (CFSEP). Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS One 2014;9:e90509 doi:10.1371/journal.pone.0090509 pmid:24598783

    CrossRefPubMed
26. 26.↵
    2. Okuda DT,
    3. Mowry EM,
    4. Cree BA, et al

    . Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology 2011;76:686–92 doi:10.1212/WNL.0b013e31820d8b1d pmid:21270417

    Abstract/FREE Full Text
27. 27.↵
    2. Kantarci OH,
    3. Lebrun C,
    4. Siva A, et al

    . Primary progressive multiple sclerosis evolving from radiologically isolated syndrome. Ann Neurol 2016;79:288–94 doi:10.1002/ana.24564 pmid:26599831

    CrossRefPubMed
28. 28.↵
    2. Barkhof F,
    3. Filippi M,
    4. Miller DH, et al

    . Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120(Pt 11):2059–69 doi:10.1093/brain/120.11.2059 pmid:9397021

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Filippi M,
    3. Rocca MA,
    4. Ciccarelli O, et al

    ; MAGNIMS Study Group. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol 2016;15:292–303 doi:10.1016/S1474-4422(15)00393-2 pmid:26822746

    CrossRefPubMed
30. 30.↵
    2. De Stefano N,
    3. Giorgio A,
    4. Tintoré M, et al

    . Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations. Mult Scler 2018;24:214–21 doi:10.1177/1352458517717808 pmid:29451440

    CrossRefPubMed
31. 31.↵
    2. Forslin Y,
    3. Granberg T,
    4. Jumah AA, et al

    . Incidence of radiologically isolated syndrome: a population-based study. AJNR Am J Neuroradiol 2016;37:1017–22 doi:10.3174/ajnr.A4660 pmid:26846927

    Abstract/FREE Full Text
32. 32.↵
    2. Alcaide-Leon P,
    3. Pauranik A,
    4. Alshafai L, et al

    . Comparison of sagittal FSE T2, STIR, and T1-weighted phase-sensitive inversion recovery in the detection of spinal cord lesions in MS at 3T. AJNR Am J Neuroradiol 2016;37:970–75 doi:10.3174/ajnr.A4656 pmid:26797141

    Abstract/FREE Full Text
33. 33.↵
    2. Huo Y,
    3. Carass A,
    4. Resnick SM, et al

    . Combining multi-atlas segmentation with brain surface estimation. Proc SPIE Int Soc Opt Eng 2016;9784 pmid:27127332

    CrossRefPubMed
34. 34.↵
    2. Nair G,
    3. Absinta M,
    4. Reich DS

    . Optimized T1-MPRAGE sequence for better visualization of spinal cord multiple sclerosis lesions at 3T. AJNR Am J Neuroradiol 2013;34:2215–22 doi:10.3174/ajnr.A3637 pmid:23764721

    Abstract/FREE Full Text
35. 35.↵
    2. Kilsdonk ID,
    3. Lopez-Soriano A,
    4. Kuijer JP, et al

    . Morphological features of MS lesions on FLAIR* at 7 T and their relation to patient characteristics. J Neurol 2014;261:1356–64 doi:10.1007/s00415-014-7351-6 pmid:24777693

    CrossRefPubMed
36. 36.↵
    2. Engell T

    . A clinical patho-anatomical study of clinically silent multiple sclerosis. Acta Neurol Scand 1989;79:428–30 doi:10.1111/j.1600-0404.1989.tb03811.x pmid:2741673

    CrossRefPubMedWeb of Science
37. 37.↵
    2. Gilbert JJ,
    3. Sadler M

    . Unsuspected multiple sclerosis. Arch Neurol 1983;40:533–36 doi:10.1001/archneur.1983.04050080033003 pmid:6615282

    CrossRefPubMedWeb of Science
38. 38.↵
    2. Castaigne P,
    3. Lhermitte F,
    4. Escourolle R, et al

    . Asymptomatic multiple sclerosis: 3 cases (author's transl) [in French]. Rev Neurol (Paris) 1981;137:729–39 pmid:7339773

    PubMed
39. 39.↵
    2. Granberg T,
    3. Martola J,
    4. Kristoffersen-Wiberg M, et al

    . Radiologically isolated syndrome: incidental magnetic resonance imaging findings suggestive of multiple sclerosis—a systematic review. Mult Scler 2013;19:271–80 doi:10.1177/1352458512451943 pmid:22760099

    CrossRefPubMed
40. 40.↵
    2. Labiano-Fontcuberta A,
    3. Benito-Leon J

    . Radiologically isolated syndrome: an update on a rare entity. Mult Scler 2016;22:1514–21 doi:10.1177/1352458516653666 pmid:27288053

    CrossRefPubMed
41. 41.↵
    2. Liu S,
    3. Kullnat J,
    4. Bourdette D, et al

    . Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients. Mult Scler 2013;19:1101–05 doi:10.1177/1352458512471874 pmid:23380650

    CrossRefPubMed
42. 42.↵
    2. Dworkin JD,
    3. Sati P,
    4. Solomon A, et al

    . Automated integration of multimodal MRI for the probabilistic detection of the central vein sign in white matter lesions. AJNR Am J Neuroradiol 2018;39:1806–13 doi:10.3174/ajnr.A5765 pmid:30213803

    Abstract/FREE Full Text
43. 43.↵
    2. Gaitń MI,
    3. de Alwis MP,
    4. Sati P, et al

    . Multiple sclerosis shrinks intralesional, and enlarges extralesional, brain parenchymal veins. Neurology 2013;80:145–51 doi:10.1212/WNL.0b013e31827b916f pmid:23255828

    Abstract/FREE Full Text